Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 1 Nov 2015

Zhang Hui, Yang Xinjie, Qin Na, Li Xi, Yang Huiyi, Nong Jingying, Lv Jialin, Wu Yuhua, Zhang Quan, Zhang Xinyong, Wang Jinghui, Zhou Lijuan, Zhang Shucai

Abstract excerpt

BACKGROUND AND OBJECTIVE: Mutations in epidermal growth factor receptor (EGFR) and KRAS are important markers in non-small cell lung cancer, which are closely related to the clinical therapeutic effect. To analysis the EGFR and KRAS gene mutation rate and its relationship with clinical features in patients with lung adenocarcinoma. METHODS: 395 patients with treatment naïve lung adenocarcinoma, tumor tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Mutation

Share to Proto-Oncogene Proteins p21(ras)

Source

Open in PubMed Open full text

Identifiers

PMID: 26582224
DOI: 10.3779/j.issn.1009-3419.2015.11.05
PMCID: PMC6000313

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].PMID 26582224Read ↗

[Detection and Analysis of EGFR and KRAS Mutations in the Patients with Lung Squamous Cell Carcinomas].Semantic proximity Read ↗

[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].Semantic proximity Read ↗

[EGFR and KRAS Gene Mutations in 754 Patients with Resectable Stage I-IIIa Non-small Cell Lung Cancer and Its Clinical Significance].Semantic proximity Read ↗

[Relationship between EGFR Mutations and Pathological Classification and Specimen of Lung Adenocarcinoma].Semantic proximity Read ↗

EGFR Mutation Detection and Its Association With Clinicopathological Characters of Lung Cancer PatientsSemantic proximity Read ↗

[Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].Semantic proximity Read ↗

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.Semantic proximity Read ↗

[KRAS status versus EGFR status in lung cancer therapy].Semantic proximity Read ↗

[Advances on driver oncogenes of non-small cell lung cancer].Semantic proximity Read ↗

KRAS mutation: should we test for it, and does it matter?Semantic proximity Read ↗

[KRAS and epidermal growth factor receptor gene mutation in non-small cell lung cancer].Semantic proximity Read ↗

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.